Table I.
Association between the RON expression and the clinical pathological features in bladder cancer.
| RON expression | |||||
|---|---|---|---|---|---|
| Variables | Patients, n | Low | High | χ2-value | P-value |
| Tissue | 15.54 | 0.000 | |||
| All tumor | 106 | 48 | 58 | ||
| Paracancerous | 34 | 28 | 6 | ||
| Sex | 2.749 | 0.097 | |||
| Male | 87 | 41 | 46 | ||
| Female | 19 | 5 | 14 | ||
| Age, years | 0.197 | 0.657 | |||
| <70 | 51 | 21 | 30 | ||
| ≥70 | 55 | 25 | 30 | ||
| Number of tumor nodules | 9.348 | 0.002 | |||
| Single | 63 | 35 | 28 | ||
| Multiple | 43 | 11 | 32 | ||
| Distant metastasis | 7.323 | 0.007 | |||
| M0 | 90 | 44 | 46 | ||
| M1 | 16 | 2 | 14 | ||
| Pathological stage | 4.652 | 0.031 | |||
| Tis-T1 | 42 | 28 | 14 | ||
| T2-T4 | 64 | 29 | 35 | ||
| Histological grading | 9.667 | 0.008 | |||
| Urothelial carcinoma, grade I | 10 | 8 | 2 | ||
| Urothelial carcinoma, grade II | 41 | 25 | 16 | ||
| Urothelial carcinoma, grade III | 55 | 20 | 35 | ||
RON, macrophage stimulating 1 receptor; T, tumor; M, metastasis.